Stock Spotlight: Innovative Industrial Properties Inc. (NYSE:IIPR)
About Innovative Industrial Properties Inc.
Innovative Industrial Properties, Inc. is a real estate investment trust (REIT) focused on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated cannabis facilities.
Key Stats
Key Stats
Source: Yahoo Finance. Data as of 02/10/25.
Price Performance
Growth Potential
- First-mover advantage in cannabis real estate (only publicly traded REIT focused on regulated cannabis cultivation and processing facilities) with deep relationships with leading multi-state operators (MSO) gives it competitive moat in form of brand recognition, tenant trust and pricing power.
- Attractive sale-leaseback economics as cannabis operators face limited access to traditional bank financing (due to federal illegality) with the company providing much-needed capital via sale-leaseback deals at high cap rates (11-15%) while locking tenants into 15-20-year triple-net leases (shifting property expenses and risks to tenants), ensuring predictable and inflation-protected income.
- High cashflow visibility with the portfolio is underpinned by long-term contracts with annual rent escalators of typically 3-4% plus property management fees with REIT structure requiring payout of >90% of taxable income, creating a strong dividend stream for investors (annual dividend/share grown at +45% CAGR 2017-2024).
- Diversified portfolio with 65% tenants’ public listed, 89% MSO and top 10 accounting for 72.7% of total investment across all product types (cultivation, processing, distribution, and retail).
- Secular cannabis growth tailwinds with the U.S. cannabis industry projected to grow at +7% CAGR 2024-2029 as more states legalize medical/adult-use cannabis with potential Federal reforms (banking access, de-scheduling) benefiting the company by reducing tenant credit risk and lowering capital costs.
- Strong balance sheet and conservative leverage gives flexibility to pursue acquisitions opportunistically during industry downturns.
Key Risks
- Adverse regulatory outcome relating to the legalization of medicinal cannabis.
- New competitors emerge making earnings growth difficult.
- Legalization of cannabis at the Federal level will see additional cheaper + easier to access capital to the industry which could depress IIPR’s returns/cap rate.
- Tenant churn or tenants defaulting.
- Turnover in the senior management team.
Subscribe to our newsletter
Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.




